Syndax Pharmaceuticals, Inc. (SNDX) Social Stream



Syndax Pharmaceuticals, Inc. (SNDX): $20.79

0.18 (-0.86%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

SYNDAX PHARMACEUTICALS INC (SNDX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SNDX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-20 5 $37 $21 $28 $22.64 23.67%
2022-03-02 4 $37 $24 $30.333 $22.64 33.98%
2022-05-10 5 $37 $24 $30.5 $22.64 34.72%
2022-05-24 4 $40 $30 $33.666 $22.64 48.7%
2022-07-28 4 $40 $31 $34 $22.64 50.18%
2022-09-29 4 $35 $31 $32.333 $22.64 42.81%
2022-11-04 4 $35 $31 $33.333 $22.64 47.23%
2022-12-12 4 $39 $33 $35.333 $22.64 56.06%
2023-01-03 5 $41 $33 $36.75 $22.64 62.32%
2023-01-31 6 $41 $33 $36.8 $22.64 62.54%
2023-03-01 6 $41 $33 $35.8 $22.64 58.13%
2023-03-02 7 $41 $32 $35.166 $22.64 55.33%
2023-03-07 7 $37 $32 $34.333 $22.64 51.65%
2023-03-15 7 $37 $32 $34 $22.64 50.18%
2023-05-09 8 $37 $32 $34 $22.64 50.18%
2023-05-10 8 $37 $31 $34.285 $22.64 51.44%
2023-05-22 8 $37 $31 $34 $22.64 50.18%
2023-06-26 8 $37 $31 $34.142 $22.64 50.8%
2023-07-11 9 $40 $31 $34.875 $22.64 54.04%
2023-07-24 9 $40 $31 $35.25 $22.64 55.7%
2023-07-25 10 $42 $31 $36.25 $22.64 60.11%
2023-07-26 10 $42 $31 $36 $22.64 59.01%
2023-07-27 10 $42 $34 $36.333 $22.64 60.48%
2023-08-04 9 $42 $34 $36.444 $22.64 60.97%
2023-08-16 9 $42 $33 $36.111 $22.64 59.5%
2023-09-05 10 $42 $34 $36.75 $22.64 62.32%
2023-10-03 10 $43 $34 $37.222 $22.64 64.41%
2023-10-11 11 $43 $30 $36.5 $22.64 61.22%
2023-10-18 11 $43 $30 $36.7 $22.64 62.1%
2023-10-25 12 $43 $29 $36 $22.64 59.01%
2023-11-03 12 $43 $29 $35.818 $22.64 58.21%
2023-12-13 12 $43 $29 $35.545 $22.64 57%
2023-12-22 13 $45 $29 $36.25 $22.64 60.11%

The Trend in the Analyst Price Target


Over the past 19 months, SNDX's average price target has gone up $2.58.

SNDX reports an average of 97.2% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-07 7 37 32 34.333 24.23 41.7%
2023-05-10 8 37 31 34.285 20.37 68.31%
2023-08-16 9 42 33 36.111 18.00 100.62%
2023-10-03 10 43 34 37.222 12.64 194.48%
2023-10-17 11 43 30 36.700 12.36 196.93%

SNDX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 13 0 0 0 0 13

The Trend in the Broker Recommendations


Over the past 26 weeks, SNDX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, SYNDAX PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1049.5% of them.
  • In terms of how SYNDAX PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is higher than 3157.49% of that group.
  • In the context of stocks in the small market cap category, SYNDAX PHARMACEUTICALS INC's average analyst price target is greater than 3314.08% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SYNDAX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1487.78% of them.

Stocks similar to SYNDAX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NEPT, CTMX, and WVE.

Is SNDX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!